@richardjbaum.bsky.social
Salvation Army faces class-action suit over denying addiction medications www.statnews.com/2025/04/16/a... via @statnews.com
Salvation Army faces class-action suit over denying addiction medications
The Salvation Army runs recovery housing but disallows addiction medicines like buprenorphine. A class-action suit could expand treatment access.
www.statnews.com
April 20, 2025 at 4:55 PM
Salvation Army faces class-action suit over denying addiction medications www.statnews.com/2025/04/16/a... via @statnews.com
apnews.com/article/john...
“He details a litany of controversies involving the company ranging from the effects of its anti-psychotic drug Risperdal to the company’s role in the nation’s opioid crisis.”
“He details a litany of controversies involving the company ranging from the effects of its anti-psychotic drug Risperdal to the company’s role in the nation’s opioid crisis.”
Book Review: 'No More Tears' scrutinizes the legacy of health giant Johnson & Johnson
In “No More Tears: The Dark Secrets of Johnson & Johnson,” veteran reporter Gardiner Harris scrutinizes the legacy of health care giant Johnson & Johnson.
apnews.com
April 12, 2025 at 11:27 AM
apnews.com/article/john...
“He details a litany of controversies involving the company ranging from the effects of its anti-psychotic drug Risperdal to the company’s role in the nation’s opioid crisis.”
“He details a litany of controversies involving the company ranging from the effects of its anti-psychotic drug Risperdal to the company’s role in the nation’s opioid crisis.”
“We really are trying to make this a community-wide effort and create a culture in our school where we can talk more openly about these issues around substance use…”
March 25, 2025 at 11:26 PM
“We really are trying to make this a community-wide effort and create a culture in our school where we can talk more openly about these issues around substance use…”
What We're Getting Right Fighting the Overdose Epidemic
www.bloomberg.com/opinion/arti...
www.bloomberg.com/opinion/arti...
What We're Getting Right Fighting the Overdose Epidemic
Deaths are down and experts agree the numbers should continue to decline so long as current efforts stay on track.
www.bloomberg.com
March 23, 2025 at 12:54 PM
What We're Getting Right Fighting the Overdose Epidemic
www.bloomberg.com/opinion/arti...
www.bloomberg.com/opinion/arti...
“Proposed cuts to Medicaid could undo advances in treatment for opioid use disorders, risking more overdoses, deaths and stress…
The total number of people treated for OUD under Medicaid in 2021 was nearly 1.82 million, or 35 percent of all people treated for the disorder in the U.S.”
The total number of people treated for OUD under Medicaid in 2021 was nearly 1.82 million, or 35 percent of all people treated for the disorder in the U.S.”
March 21, 2025 at 12:27 AM
“Proposed cuts to Medicaid could undo advances in treatment for opioid use disorders, risking more overdoses, deaths and stress…
The total number of people treated for OUD under Medicaid in 2021 was nearly 1.82 million, or 35 percent of all people treated for the disorder in the U.S.”
The total number of people treated for OUD under Medicaid in 2021 was nearly 1.82 million, or 35 percent of all people treated for the disorder in the U.S.”
At a recent Nevada legislative committee hearing, lawmakers faced off with members of the governor's administration over how to fill gaping holes in the state's…
February 27, 2025 at 12:54 AM
At a recent Nevada legislative committee hearing, lawmakers faced off with members of the governor's administration over how to fill gaping holes in the state's…
A decision about how to spend settlement funds in Carter County, Kentucky, which was hit hard by the opioid epidemic, offers a window into the choices that surr…
February 23, 2025 at 1:38 PM
A decision about how to spend settlement funds in Carter County, Kentucky, which was hit hard by the opioid epidemic, offers a window into the choices that surr…
“Now, these drugs are being investigated for a new and unexpected application: opioid use disorder (OUD)”
www.pharmaceutical-technology.com/features/glp...
www.pharmaceutical-technology.com/features/glp...
GLP-1RAs and opioid use disorder: a new frontier in addiction treatment - Pharmaceutical Technology
An NIH-funded clinical trial is underway investigating GLP-1RAs as a treatment for opioid use disorder.
www.pharmaceutical-technology.com
February 20, 2025 at 2:42 AM
“Now, these drugs are being investigated for a new and unexpected application: opioid use disorder (OUD)”
www.pharmaceutical-technology.com/features/glp...
www.pharmaceutical-technology.com/features/glp...